Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5524 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Hyun Young Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, AMP-Activated Protein Kinases, Signal Transduction, Pyrazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Compound C is an adenosine monophosphate‑activated protein kinase (AMPK) inhibitor, which is also recognized as a broad‑spectrum kinase inhibitor with anti‑proliferative effects. The present study investigated the therapeutic effects of a high concentration of compound C on Graves' orbitopathy (GO) pathogenesis beyond the AMPK‑dependent pathway using human orbital fibroblasts. Orbital connective tissue was obtained from patients with GO and healthy controls, and primary orbital fibroblasts were cultured. The cells were then pretreated with a non‑cytotoxic concentration of compound C, and stimulated with either IL‑1β or TGF‑β. Pro‑inflammatory cytokine expression, profibrotic protein production and adipogenesis were evaluated using western blotting and Oil Red O staining. Adipocyte differentiation following knockdown of the hippocampal signaling pathway was also analyzed. Hyaluronan secretion was assessed using ELISA. Notably, treatment with a non‑cytotoxic concentration of compound C (10 µM) significantly suppressed AMPK and yes‑associated protein (YAP) phosphorylation in orbital fibroblasts. In addition, compound C suppressed IL‑1β‑induced pro‑inflammatory cytokine production and TGF‑β‑induced profibrotic protein production, as well as the phosphorylation of Akt, SMAD 1/2/3, and hyaluronan secretion. Similar to compound C treatment, silencing YAP and transcriptional co‑activator with PDZ‑binding motif, significantly attenuated adipogenesis as determined by Oil Red O quantification and the production of adipogenic markers. It may be hypothesized that a high concentration of compound C suppresses inflammation, fibrosis and adipogenesis in orbital fibroblasts through YAP inactivation, since YAP knockdown effectively reduced adipogenesis in GO orbital fibroblasts. Taken together, these findings suggested that compound C may exert its therapeutic effects through an AMPK‑independent mechanism, inhibiting inflammation, adipogenesis and fibrosis in orbital fibroblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Zitieren
APA
Park, H. Y., Choi, S. H., Lee, H. S., Ko, J., & Yoon, J. S. (2025). Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5524
Vancouver
Park HY, Choi SH, Lee HS, Ko J, Yoon JS. Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways. International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5524
BibTeX
@article{Park2025,
author = {Park, Hyun Young and Choi, Soo Hyun and Lee, Hyeon Seo and Ko, Jaesang and Yoon, Jin Sook},
title = {Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5524}
}
EUVIMED